Glutathione depletion and neuronal cell death: the role of reactive oxygen intermediates and mitochondrial function.
Glutathione (GSH) levels are supposed to determine the vulnerability of many cells towards a wide array of insults. We investigated the effects of chronic inhibition of GSH synthesis and acute depletion of GSH on cerebellar granule neurons in vitro and determined cytoplasmic and mitochondrial GSH with relation to mitochondrial function and generation of reactive oxygen intermediates (ROI). l-buthionine sulfoximine (BSO), which irreversibly blocks gamma-glutamyl-cysteine synthase, led to a time- and concentration-dependent loss of cytoplasmic GSH, while mitochondrial GSH was relatively preserved. No increased generation of ROI was detected over 48 h and the mitochondrial membrane potential was largely maintained. Neuronal degeneration occurred when mitochondrial GSH levels had fallen below 50% of control after 24-36 h. In contrast, direct conjugation of mitochondrial and cytoplasmic GSH with etacrynic acid (EA), resulted in immediate loss of mitochondrial GSH, a large increase of ROI within 2 h, subsequent collapse of the mitochondrial membrane potential and complete cell death within 4-8 h. Electron microscopy studies revealed an as yet unknown change of the chromatin structure to a homogeneous granular pattern after BSO, while EA resulted in typical necrotic changes. No typical features of apoptosis, i.e., no chromatin condensation or DNA fragmentation were detected after GSH depletion after BSO or EA treatment.
Wüllner
U
U
Department of Neurology, Eberhard-Karls-University, Hoppe-Seyler-Str. 3, D-72076, Tübingen, Germany. wuellner@uni-bonn.de
Seyfried
J
J
Groscurth
P
P
Beinroth
S
S
Winter
S
S
Gleichmann
M
M
Heneka
M
M
Löschmann
P
P
Schulz
J B
JB
Weller
M
M
Klockgether
T
T
D000818:Animals; D000963:Antimetabolites / Q000494:pharmacology; D017209:Apoptosis / Q000502:physiology*; D006690:Bisbenzimidazole; D019328:Buthionine Sulfoximine / Q000494:pharmacology; D002531:Cerebellum / Q000166:cytology; D003513:Cycloheximide / Q000494:pharmacology; D053938:DNA Fragmentation; D005456:Fluorescent Dyes; D005978:Glutathione / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D008854:Microscopy, Electron; D008928:Mitochondria / Q000378:metabolism*; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000648:ultrastructure; D011500:Protein Synthesis Inhibitors / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017382:Reactive Oxygen Species / Q000378:metabolism*
D000963:Antimetabolites; D005456:Fluorescent Dyes; D011500:Protein Synthesis Inhibitors; D017382:Reactive Oxygen Species; C077304:glutathione glycylethyl ester; D019328:Buthionine Sulfoximine; D003513:Cycloheximide; D005978:Glutathione; D006690:Bisbenzimidazole